The DOI matches its Crossref record; 1,227 of the 1,227 references it cites were found in a registry or an index.
Dopamine, Immunity, and Disease
Open accessAbstract
The neurotransmitter dopamine is a key factor in central nervous system (CNS) function, regulating many processes including reward, movement, and cognition. Dopamine also regulates critical functions in peripheral organs, such as blood pressure, renal activity, and intestinal motility. Beyond these functions, a growing body of evidence indicates that dopamine is an important immunoregulatory factor. Most types of immune cells express dopamine receptors and other dopaminergic proteins, and many immune cells take up, produce, store, and/or release dopamine, suggesting that dopaminergic immunomodulation is important for immune function. Targeting these pathways could be a promising avenue for the treatment of inflammation and disease, but despite increasing research in this area, data on the specific effects of dopamine on many immune cells and disease processes remain inconsistent and poorly understood. Therefore, this review integrates the current knowledge of the role of dopamine in immune cell function and inflammatory signaling across systems. We also discuss the current understanding of dopaminergic regulation of immune signaling in the CNS and peripheral tissues, highlighting the role of dopaminergic immunomodulation in diseases such as Parkinson's disease, several neuropsychiatric conditions, neurologic human immunodeficiency virus, inflammatory bowel disease, rheumatoid arthritis, and others. Careful consideration is given to the influence of experimental design on results, and we note a number of areas in need of further research. Overall, this review integrates our knowledge of dopaminergic immunology at the cellular, tissue, and disease level and prompts the development of therapeutics and strategies targeted toward ameliorating disease through dopaminergic regulation of immunity. SIGNIFICANCE STATEMENT: Canonically, dopamine is recognized as a neurotransmitter involved in the regulation of movement, cognition, and reward. However, dopamine also acts as an immune modulator in the central nervous system and periphery. This review comprehensively assesses the current knowledge of dopaminergic immunomodulation and the role of dopamine in disease pathogenesis at the cellular and tissue level. This will provide broad access to this information across fields, identify areas in need of further investigation, and drive the development of dopaminergic therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 401–600 of 1,227
Imaging neurotransmitter and neuromodulator dynamics in vivo with genetically encoded indicators
Sabatini, B. L., & Tian, L. (2020) · Neuron · doi:10.1016/j.neuron.2020.09.036 · Cited by 203
Nitric oxide increases dopamine and serotonin release in the medial preoptic area
Lorrain, D. S., & Hull, E. M. (1993) · NeuroReport · doi:10.1097/00001756-199310000-00024 · Cited by 200
The role of dopamine signaling in epileptogenesis
Bozzi, Y., & Borrelli, E. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00157 · Cited by 199
CNS Inflammation and Macrophage/Microglial Biology Associated with HIV-1 Infection
Yadav, A., & Collman, R. G. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9174-2 · Cited by 199
The Modulatory Role of Dopamine in Anxiety-like Behavior.
Zarrindast, M., & Khakpai, F. (2015) · PubMed · Cited by 199
Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences
Aringhieri, S., Carli, M., Kolachalam, S., Verdesca, V., Cini, E., Rossi, M., McCormick, P. J., Corsini, G. U., Maggio, R., & Scarselli, M. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.06.012 · Cited by 199
Howes, O. D., Williams, M., Ibrahim, K., Leung, G., Egerton, A., McGuire, P. K., & Turkheimer, F. (2013) · Brain · doi:10.1093/brain/awt264 · Cited by 198
Cyclic AMP: a selective modulator of NF-κB action
Gerlo, S., Kooijman, R., Beck, I. M., Kolmus, K., Spooren, A., & Haegeman, G. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0757-8 · Cited by 198
Mar Fan, H. G., Clemons, M., Xu, W., Chemerynsky, I., Breunis, H., Braganza, S., & Tannock, I. F. (2008) · Supportive Care in Cancer · doi:10.1007/s00520-007-0341-9 · Cited by 198
Zayyad, Z., & Spudich, S. (2015) · Current HIV/AIDS Reports · doi:10.1007/s11904-014-0255-3 · Cited by 198
Li, Z. S., Pham, T. D., Tamir, H., Chen, J. J., & Gershon, M. D. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3982-03.2004 · Cited by 197
Ko, A., Kang, G., Hattler, J. B., Galadima, H. I., Zhang, J., Li, Q., & Kim, W.-K. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9809-2 · Cited by 197
Müller, T., Blum-Degen, D., Przuntek, H., & Kuhn, W. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1998.tb01736.x · Cited by 195
EDVINSSON, L., CERVÓS-NAVARRO, J., LARSSON, L.-I., OWMAN, C., & RONNBERG, A.-L. (1977) · Neurology · doi:10.1212/wnl.27.9.878 · Cited by 192
Zeier, Z., Carpenter, L. L., Kalin, N. H., Rodriguez, C. I., McDonald, W. M., Widge, A. S., & Nemeroff, C. B. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.17111282 · Cited by 192
Bido, S., Muggeo, S., Massimino, L., Marzi, M. J., Giannelli, S. G., Melacini, E., Nannoni, M., Gambarè, D., Bellini, E., Ordazzo, G., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26519-x · Cited by 190
Treatment of adults with attention-deficit/hyperactivity disorder
Hechtman, L. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s6985 · Cited by 189
Neuroinflammation and protein pathology in Parkinson’s disease dementia
Kouli, A., Camacho, M., Allinson, K., & Williams-Gray, C. H. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01083-5 · Cited by 189
Wang, B., Yang, L.-P., Zhang, X.-Z., Huang, S.-Q., Bartlam, M., & Zhou, S.-F. (2009) · Drug Metabolism Reviews · doi:10.1080/03602530903118729 · Cited by 188
Drug-Metabolizing Enzymes in the Skin of Man, Rat, and Pig
Oesch, F., Fabian, E., Oesch-Bartlomowicz, B., Werner, C., & Landsiedel, R. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530701690366 · Cited by 188
Neuroinflammation in treated HIV-positive individuals: A TSPO PET study
Vera, J. H., Guo, Q., Cole, J. H., Boasso, A., Greathead, L., Kelleher, P., Rabiner, E. A., Kalk, N., Bishop, C., Gunn, R. N., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002485 · Cited by 188
β-amyloid, microglia, and the inflammasome in Alzheimer’s disease
Gold, M., & El Khoury, J. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0518-0 · Cited by 187
Corelease of Dopamine and Serotonin from Striatal Dopamine Terminals
Zhou, F.-M., Liang, Y., Salas, R., Zhang, L., De Biasi, M., & Dani, J. A. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.010 · Cited by 187
Kipnis, J., Cardon, M., Avidan, H., Lewitus, G. M., Mordechay, S., Rolls, A., Shani, Y., & Schwartz, M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0600-04.2004 · Cited by 187
Antonini, A., Leenders, K. L., Reist, H., Thomann, R., Beer, H.-F., & Locher, J. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540050026010 · Cited by 186
Mattei, D., Djodari-Irani, A., Hadar, R., Pelz, A., de Cossío, L. F., Goetz, T., Matyash, M., Kettenmann, H., Winter, C., & Wolf, S. A. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.01.019 · Cited by 186
Haney, M., Ward, A., Foltin, R., & Fischman, M. (2001) · Psychopharmacology · doi:10.1007/s002130100725 · Cited by 186
Evidence for a critical role of the sympathetic nervous system in hypertension
Grassi, G., & Ram, V. S. (2016) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2016.02.015 · Cited by 186
Joseph, S. B., Arrildt, K. T., Sturdevant, C. B., & Swanstrom, R. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-014-0287-x · Cited by 185
von Herrmann, K. M., Salas, L. A., Martinez, E. M., Young, A. L., Howard, J. M., Feldman, M. S., Christensen, B. C., Wilkins, O. M., Lee, S. L., Hickey, W. F., et al. (2018) · npj Parkinson's Disease · doi:10.1038/s41531-018-0061-5 · Cited by 184
Baumeister, D., Ciufolini, S., & Mondelli, V. (2016) · Psychopharmacology · doi:10.1007/s00213-015-4044-5 · Cited by 183
The potential role of dopamine D3 receptor neurotransmission in cognition
Nakajima, S., Gerretsen, P., Takeuchi, H., Caravaggio, F., Chow, T., Le Foll, B., Mulsant, B., Pollock, B., & Graff-Guerrero, A. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.05.006 · Cited by 183
Sodium Diuresis Produced by Dopamine in Patients with Congestive Heart Failure
Goldberg, L. I., McDonald, R. H., & Zimmerman, A. M. (1963) · New England Journal of Medicine · doi:10.1056/nejm196311142692003 · Cited by 183
Association between the dopamine transporter gene and posttraumatic stress disorder
Segman, R. H., Cooper-Kazaz, R., Macciardi, F., Goltser, T., Halfon, Y., Dobroborski, T., & Shalev, A. Y. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001085 · Cited by 182
Gerits, N., Kostenko, S., Shiryaev, A., Johannessen, M., & Moens, U. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.02.022 · Cited by 182
Upregulation of Melanogenesis and Tyrosinase Activity: Potential Agents for Vitiligo
Niu, C., & Aisa, H. A. (2017) · Molecules · doi:10.3390/molecules22081303 · Cited by 182
Dopamine release is heterogeneous within microenvironments of the rat nucleus accumbens
Wightman, R. M., Heien, M. L. A. V., Wassum, K. M., Sombers, L. A., Aragona, B. J., Khan, A. S., Ariansen, J. L., Cheer, J. F., Phillips, P. E. M., & Carelli, R. M. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05772.x · Cited by 180
Antonini, A., Schwarz, J., Oertel, W. H., et al. (1994) · Neurology · doi:10.1212/wnl.44.7.1325 · Cited by 178
Profiling inflammatory signatures of schizophrenia: A cross-sectional and meta-analysis study
Frydecka, D., Krzystek-Korpacka, M., Lubeiro, A., Stramecki, F., Stańczykiewicz, B., Beszłej, J. A., Piotrowski, P., Kotowicz, K., Szewczuk-Bogusławska, M., Pawlak-Adamska, E., et al. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.05.002 · Cited by 178
Reduced skin homing by functional Treg in vitiligo: Absence of Treg in vitiligo skin
Klarquist, J., Denman, C. J., Hernandez, C., Wainwright, D. J., Strickland, F. M., Overbeck, A., Mehrotra, S., Nishimura, M. I., & Le Poole, I. C. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00688.x · Cited by 176
Polymorphisms in dopamine receptors: what do they tell us?
Hung Choy Wong, A., Buckle, C. E., & Van Tol, H. H. M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00815-3 · Cited by 176
The Choroid Plexus in Healthy and Diseased Brain
Kaur, C., Rathnasamy, G., & Ling, E.-A. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlv030 · Cited by 176
Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial
Arnow, B. A., Blasey, C., Williams, L. M., Palmer, D. M., Rekshan, W., Schatzberg, A. F., Etkin, A., Kulkarni, J., Luther, J. F., & Rush, A. J. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14020181 · Cited by 175
Moraska, A. R., Sood, A., Dakhil, S. R., Sloan, J. A., Barton, D., Atherton, P. J., Suh, J. J., Griffin, P. C., Johnson, D. B., Ali, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.1444 · Cited by 175
Increased Oxidative Stress Exacerbates α-Synuclein Aggregation In Vivo
Scudamore, O., & Ciossek, T. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly024 · Cited by 175
Zhang, J., He, H., Qiao, Y., Zhou, T., He, H., Yi, S., Zhang, L., Mo, L., Li, Y., Jiang, W., et al. (2020) · Glia · doi:10.1002/glia.23878 · Cited by 174
Antonini, A., Vontobel, P., Psylla, M., Gunther, I., Maguire, P. R., Missimer, J., & Leenders, K. L. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540360061017 · Cited by 174
Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum
Rassoulpour, A., Wu, H., Ferrė, S., & Schwarcz, R. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03134.x · Cited by 174
Zhang, Y., Catts, V. S., Sheedy, D., McCrossin, T., Kril, J. J., & Shannon Weickert, C. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.238 · Cited by 174
Gershen, L. D., Zanotti-Fregonara, P., Dustin, I. H., Liow, J.-S., Hirvonen, J., Kreisl, W. C., Jenko, K. J., Inati, S. K., Fujita, M., Morse, C. L., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.0941 · Cited by 173
Karpenko, M. N., Vasilishina, A. A., Gromova, E. A., Muruzheva, Z. M., & Bernadotte, A. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.02.011 · Cited by 172
Zhu, J., Hu, Z., Han, X., Wang, D., Jiang, Q., Ding, J., Xiao, M., Wang, C., Lu, M., & Hu, G. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-018-0127-2 · Cited by 171
Upregulation of Phagocyte-Derived Catecholamines Augments the Acute Inflammatory Response
Flierl, M. A., Rittirsch, D., Nadeau, B. A., Sarma, J. V., Day, D. E., Lentsch, A. B., Huber-Lang, M. S., & Ward, P. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004414 · Cited by 170
Levodopa-induced dyskinesia: clinical features, incidence, and risk factors
Tran, T. N., Vo, T. N. N., Frei, K. P., & Truong, D. D. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1900-6 · Cited by 170
Ilani, T., Ben-Shachar, D., Strous, R. D., Mazor, M., Sheinkman, A., Kotler, M., & Fuchs, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.625 · Cited by 169
Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension.
Asico, L. D., Ladines, C. A., Fuchs, S., Accili, D., Carey, R. M., Semeraro, C., Pocchiari, F., Felder, R. A., Eisner, G. M., & José, P. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3685 · Cited by 169
An astroglia-linked dopamine D2-receptor action in prefrontal cortex
Khan, Z. U., Koulen, P., Rubinstein, M., Grandy, D. K., & Goldman-Rakic, P. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1964 · Cited by 169
Dopaminergic neuron-specific oxidative stress caused by dopamine itself.
Miyazaki, I., & Asanuma, M. (2008) · PubMed · doi:10.18926/amo/30942 · Cited by 168
Neuroimmune biomarkers in schizophrenia
Tomasik, J., Rahmoune, H., Guest, P. C., & Bahn, S. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.07.025 · Cited by 168
A Review on the Role of Inflammation in Attention-Deficit/Hyperactivity Disorder
Leffa, D. T., Torres, I. L. S., & Rohde, L. A. (2018) · Neuroimmunomodulation · doi:10.1159/000489635 · Cited by 168
Subcortical brain atrophy persists even in HAART-regulated HIV disease
Study, M. A. C., Becker, J. T., Sanders, J., Madsen, S. K., Ragin, A., Kingsley, L., Maruca, V., Cohen, B., Goodkin, K., Martin, E., et al. (2011) · Brain Imaging and Behavior · doi:10.1007/s11682-011-9113-8 · Cited by 167
Homeostatic mechanisms in dopamine synthesis and release: a mathematical model
Best, J. A., Nijhout, H. F., & Reed, M. C. (2009) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-6-21 · Cited by 167
Microglial activation in a neuroinflammational animal model of schizophrenia – a pilot study
Juckel, G., Manitz, M. P., Brüne, M., Friebe, A., Heneka, M. T., & Wolf, R. J. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.06.018 · Cited by 165
King, C. D., Rios, G. R., Assouline, J. A., & Tephly, T. R. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1155 · Cited by 165
Induction of Pathogenic Sets of Genes in Macrophages and Neurons in NeuroAIDS
Roberts, E. S., Zandonatti, M. A., Watry, D. D., Madden, L. J., Henriksen, S. J., Taffe, M. A., & Fox, H. S. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64336-2 · Cited by 164
Sugama, S., Yang, L., Cho, B. P., DeGiorgio, L. A., Lorenzl, S., Albers, D. S., Beal, M. F., Volpe, B. T., & Joh, T. H. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04085-4 · Cited by 164
Sayyah, M., Javad-Pour, M., & Ghazi-Khansari, M. (2003) · Neuroscience · doi:10.1016/j.neuroscience.2003.08.043 · Cited by 164
Biological markers of generalized anxiety disorder
Maron, E., & Nutt, D. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.2/dnutt · Cited by 164
Williams, D. W., Calderon, T. M., Lopez, L., Carvallo-Torres, L., Gaskill, P. J., Eugenin, E. A., Morgello, S., & Berman, J. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069270 · Cited by 163
Self-citationHeteromeric Dopamine Receptor Signaling Complexes: Emerging Neurobiology and Disease Relevance
Perreault, M. L., Hasbi, A., O'Dowd, B. F., & George, S. R. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.148 · Cited by 163
Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses
Genro, J. P., Kieling, C., Rohde, L. A., & Hutz, M. H. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.17 · Cited by 163
Oades, R. D., Myint, A.-M., Dauvermann, M. R., SCHIMMELMANN, B. G., & Schwarz, M. (2010) · Behavioral and Brain Functions · doi:10.1186/1744-9081-6-32 · Cited by 163
TFH-derived dopamine accelerates productive synapses in germinal centres
Papa, I., Saliba, D., Ponzoni, M., Bustamante, S., Canete, P. F., Gonzalez-Figueroa, P., McNamara, H. A., Valvo, S., Grimbaldeston, M., Sweet, R. A., et al. (2017) · Nature · doi:10.1038/nature23013 · Cited by 163
Do your gut microbes affect your brain dopamine?
González‐Arancibia, C., Urrutia-Piñones, J., Illanes-González, J., Martínez-Pinto, J., Sotomayor‐Zárate, R., Julio‐Pieper, M., & Bravo, J. A. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05265-5 · Cited by 163
Comer, A. L., Jinadasa, T., Sriram, B., Phadke, R. A., Kretsge, L. N., Nguyen, T. P. H., Antognetti, G., Gilbert, J. P., Lee, J., Newmark, E. R., et al. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000604 · Cited by 163
Cell trafficking through the choroid plexus
Meeker, R. B., Williams, K., Killebrew, D. A., & Hudson, L. C. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.21054 · Cited by 162
β‐arrestins and heterotrimeric G‐proteins: collaborators and competitors in signal transduction
DeFea, K. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707508 · Cited by 162
Bone health in Parkinson's disease: a systematic review and meta-analysis
Torsney, K. M., Noyce, A. J., Doherty, K. M., Bestwick, J. P., Dobson, R., & Lees, A. J. (2014) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-307307 · Cited by 162
Avalos, C. R., Abreu, C. M., Queen, S. E., Li, M., Price, S. L., Shirk, E. N., Engle, E. L., Forsyth, E. R., Bullock, B. T., Gabhann, F. M., et al. (2017) · mBio · doi:10.1128/mbio.01186-17 · Cited by 162
Depression and Osteoporosis: A Research Synthesis with Meta-Analysis
Cizza, G., Primma, S., Coyle, M., Gourgiotis, L., & Csákó, G. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0030-1252020 · Cited by 161
Neuroimmune Mechanisms of Alcohol and Drug Addiction
Cui, C., Shurtleff, D., & Harris, R. A. (2014) · International Review of Neurobiology · doi:10.1016/b978-0-12-801284-0.00001-4 · Cited by 161
Mechanisms and regulation of dopamine release
Liu, C., & Kaeser, P. S. (2019) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2019.01.001 · Cited by 161
Gelman, B. B. (2015) · Current HIV/AIDS Reports · doi:10.1007/s11904-015-0266-8 · Cited by 160
Meyer, U., Engler, A., Weber, L., Schedlowski, M., & Feldon, J. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.04.031 · Cited by 160
The Dopaminergic System in Autoimmune Diseases
Pacheco, R., Contreras, F., & Zouali, M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00117 · Cited by 160
Williams, D., Veenstra, M., Gaskill, P., Morgello, S., Calderon, T., & Berman, J. (2014) · Current HIV Research · doi:10.2174/1570162x12666140526114526 · Cited by 160
Self-citationInflammatory signaling mechanisms in bipolar disorder
Jones, G. H., Vecera, C. M., Pinjari, O. F., & Machado‐Vieira, R. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00742-6 · Cited by 160
Dopamine D3 receptor as a new pharmacological target for the treatment of depression
Leggio, G. M., Salomone, S., Bucolo, C., Platania, C. B. M., Micale, V., Caraci, F., & Drago, F. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.07.022 · Cited by 159
Renal Dopamine System: Paracrine Regulator of Sodium Homeostasis and Blood Pressure
Carey, R. M. (2001) · Hypertension · doi:10.1161/hy0901.096422 · Cited by 159
Chen, M.-H., Li, C.-T., Lin, W.-C., Hong, C.-J., Tu, P.-C., Bai, Y.-M., Cheng, C.-M., & Su, T.-P. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.08.078 · Cited by 159
Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders
Fantuzzi, L., Tagliamonte, M., Gauzzi, M. C., & Lopalco, L. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03255-6 · Cited by 159
Neural basis of psychosis-related behaviour in the infection model of schizophrenia
Meyer, U., & Feldon, J. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.12.022 · Cited by 158
Microglial responses to dopamine in a cell culture model of Parkinson's disease
Mastroeni, D., Grover, A., Leonard, B. W., Joyce, J. N., Coleman, P. D., Kozik, B., Bellinger, D. L., & Rogers, J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.001 · Cited by 158
Zhang, Y., Chen, Y., Wu, J., Manaenko, A., Yang, P., Tang, J., Fu, W., & Zhang, J. H. (2015) · Stroke · doi:10.1161/strokeaha.115.009792 · Cited by 158
Microglial phenotypes in the human epileptic temporal lobe
Morin‐Brureau, M., Milior, G., Royer, J., Chali, F., Duigou, C. L., Savary, E., Blugeon, C., Jourdren, L., Akbar, D., Dupont, S., et al. (2018) · Brain · doi:10.1093/brain/awy276 · Cited by 158
Dopamine outside the brain: The eye, cardiovascular system and endocrine pancreas
Bucolo, C., Leggio, G. M., Drago, F., & Salomone, S. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.07.003 · Cited by 158
Richard, K. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.6.2734 · Cited by 158
Kebabian, J. W. (1978) · Life Sciences · doi:10.1016/0024-3205(78)90157-1 · Cited by 156
Campolo, M., Paterniti, I., Siracusa, R., Filippone, A., Esposito, E., & Cuzzocrea, S. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.12.003 · Cited by 156
The NLRP3 Inflammasome is Involved in the Pathogenesis of Parkinson’s Disease in Rats
Mao, Z., Liu, C., Ji, S., Yang, Q., Ye, H., Han, H., & Xue, Z. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2185-0 · Cited by 155
Post-ingestive positive controls of ingestive behavior
Sclafani, A. J. (2001) · Appetite · doi:10.1006/appe.2000.0370 · Cited by 154
The Role of Dopamine in Symptoms and Treatment of Apathy in Alzheimer's Disease
Mitchell, R. A., Herrmann, N., & Lanctôt, K. L. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00161.x · Cited by 153
Immunomodulatory Effects Mediated by Dopamine
Arreola, R., Álvarez-Herrera, S., Pérez‐Sánchez, G., Becerril‐Villanueva, E., Cruz-Fuentes, C. S., Flores-Gutiérrez, E. O., Garcés-Alvarez, M. E., de la Cruz-Aguilera, D. L., Medina‐Rivero, E., Hurtado‐Alvarado, G., et al. (2016) · Journal of Immunology Research · doi:10.1155/2016/3160486 · Cited by 153
Can’t or Won’t? Immunometabolic Constraints on Dopaminergic Drive
Treadway, M. T., Cooper, J. A., & Miller, A. H. (2019) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2019.03.003 · Cited by 153
Regulation of natural killer cell activity by glucocorticoids, serotonin, dopamine, and epinephrine
Capellino, S., Claus, M., & Watzl, C. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0477-9 · Cited by 153
MURPHY, K. M. M., Travers, P. J., & Walport, M. J. (2009) · Spektrum Akademischer Verlag eBooks · doi:10.1007/978-3-8274-2219-4 · Cited by 153
Chang, L., Wang, G., Volkow, N. D., Ernst, T. M., Telang, F., Logan, J., & Fowler, J. S. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.05.011 · Cited by 151
The role of astrocytes in the physiology and pathology of the central nervous system
Markiewicz, I., & Lukomska, B. (2006) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2006-1623 · Cited by 151
Wang, H. Y., Undie, A. S., & Friedman, E. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10589-0 · Cited by 151
Nagai, Y., Ueno, S., Saeki, Y., Soga, F., Hirano, M., & Yanagihara, T. (1996) · Neurology · doi:10.1212/wnl.46.3.791 · Cited by 150
Nakano, K., Higashi, T., Hashimoto, K., Takagi, R., Tanaka, Y., & Matsushita, S. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.012 · Cited by 149
Rascol, O., Nutt, J. G., Blin, O. J., Goetz, C. G., Trugman, J. M., Soubrouillard, C., Carter, J. H., Currie, L. J., Fabre, N., Thalamas, C., et al. (2001) · Archives of Neurology · doi:10.1001/archneur.58.2.249 · Cited by 149
Chaurasia, S. S., Lim, R. R., Parikh, B. H., Wey, Y. S., Tun, S. B. B., Wong, T. Y., Luu, C. D., Agrawal, R. V., Ghosh, A., Mortellaro, A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21198-z · Cited by 148
Garvey, L. J., Pavese, N., Politis, M., Ramlackhansingh, A. F., Brooks, D. J., Taylor-Robinson, S. D., & Winston, A. (2013) · AIDS · doi:10.1097/01.aids.0000432467.54003.f7 · Cited by 147
Pharmacology of signaling induced by dopamine D1-like receptor activation
Undieh, A. S. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.05.003 · Cited by 147
Focal application of alcohols elevates extracellular dopamine in rat brain: a microdialysis study
Wozniak, K. M., Pert, A., Mele, A., & Linnoila, M. (1991) · Brain Research · doi:10.1016/0006-8993(91)90489-i · Cited by 147
Methamphetamine Enhances HIV Infection of Macrophages
Liang, H., Wang, X., Chen, H., Li, S., Ye, L., Wang, S.-H., Wang, Y., Zhou, L., & Ho, W. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070971 · Cited by 147
Stimulated D1 dopamine receptors couple to multiple Gα proteins in different brain regions
Jin, L., Wang, H., & Friedman, E. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00470.x · Cited by 145
Lyons, D. J., Hellysaz, A., & Broberger, C. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0129-12.2012 · Cited by 145
Velozo, H. G., Contreras, F., Prado, C. E., Elgueta, D., Demane, D. F., Bernales, S., & Pacheco, R. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203121 · Cited by 145
Role of dopamine in the physiology of T-cells and dendritic cells
Pacheco, R., Prado, C. E., Barrientos, M. J., & Bernales, S. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.07.018 · Cited by 142
Morrone, A., Picardo, M., Luca, C. D., TERMINALI, O., Passi, S., & IPPOLITO, F. (1992) · Pigment Cell Research · doi:10.1111/j.1600-0749.1992.tb00003.x · Cited by 142
Dopamine and Renal Function and Blood Pressure Regulation
Armando, I., Villar, V. A. M., & José, P. A. (2011) · Comprehensive physiology · doi:10.1002/cphy.c100032 · Cited by 142
Diamond, M., Kelly, J. P., & Connor, T. J. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.11.011 · Cited by 141
Nonsteroidal anti‐inflammatory drugs and risk of Parkinson's disease
Ton, T. G. N., Heckbert, S. R., Longstreth, W. T., Jr., Rossing, M. A., Kukull, W. A., Franklin, G. M., Swanson, P. D., Smith‐Weller, T., & Checkoway, H. (2006) · Movement Disorders · doi:10.1002/mds.20856 · Cited by 141
Hardy, S. E. (2009) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2009.02.006 · Cited by 140
Cholinergic connectivity: it's implications for psychiatric disorders
Scarr, E., Gibbons, A. S., Neo, J. H., Udawela, M., & Dean, B. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00055 · Cited by 140
Human Immunodeficiency Virus (HIV) Infection of Human Macrophages Is Increased by Dopamine
Gaskill, P. J., Calderon, T. M., Luers, A. J., Eugenin, E. A., Javitch, J. A., & Berman, J. W. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081067 · Cited by 139
Self-citationSchizophrenia and dopamine receptors
Seeman, P. M. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.06.005 · Cited by 139
Proximal Tubular Secretory Clearance
Wang, K., & Kestenbaum, B. R. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12001017 · Cited by 139
Immune changes and neurotransmitters: Possible interactions in depression?
Sperner‐Unterweger, B., Kohl, C. A., & Fuchs, D. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.006 · Cited by 138
Sulfonation in Pharmacology and Toxicology
Kauffman, F. C. (2004) · Drug Metabolism Reviews · doi:10.1081/dmr-200033496 · Cited by 138
Levite, M., Chowers, Y., Ganor, Y., Besser, M. J., Hershkovits, R., & Cahalon, L. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200112)31:12<3504::aid-immu3504>3.0.co;2-f · Cited by 138
Dopamine released by dendritic cells polarizes Th2 differentiation
Nakano, K., Higashi, T., Takagi, R., Hashimoto, K., Tanaka, Y., & Matsushita, S. (2009) · International Immunology · doi:10.1093/intimm/dxp033 · Cited by 138
Myöhänen, T. T., Schendzielorz, N., & Männistö, P. T. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06723.x · Cited by 137
Imamura, K., Hishikawa, N., Ono, K., Suzuki, H., Sawada, M., Nagatsu, T., Yoshida, M., & Hashizume, Y. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0919-y · Cited by 137
Kaasinen, V., Ruottinen, H., Någren, K., Lehikoinen, P., Oikonen, V., & Rinne, J. (2000) · PubMed · Cited by 137
Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
Lucido, M. J., Bekhbat, M., Goldsmith, D. R., Treadway, M. T., Haroon, E., Felger, J. C., & Miller, A. H. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000043 · Cited by 137
The risk of Parkinson’s disease in inflammatory bowel disease: A systematic review and meta-analysis
Zhu, F., Li, C., Gong, J., Zhu, W., Gu, L., & Li, N. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.09.017 · Cited by 136
Beom, S., Cheong, D.-W., Torres, G. E., Caron, M. G., & Kim, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403899200 · Cited by 136
McClain, J. L., Fried, D. E., & Gulbransen, B. D. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.08.004 · Cited by 136
Bertorello, A. M., Hökfelt, T., Goldstein, M., & Aperia, A. C. (1988) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1988.254.6.f795 · Cited by 136
Dopaminergic Regulation of Innate Immunity: a Review
Pinoli, M., Marino, F., & Cosentino, M. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9749-2 · Cited by 136
Long-term effects of maternal immune activation on depression-like behavior in the mouse
Khan, D., Fernando, P. M., Cicvaric, A., Berger, A., Pollak, A. J., Monje, F. J., & Pollak, D. D. (2014) · Translational Psychiatry · doi:10.1038/tp.2013.132 · Cited by 135
Clinical review: immunomodulatory effects of dopamine in general inflammation.
Beck, G. C., Brinkkoetter, P. T., Hanusch, C., Schulte, J., van Ackern, K., van der Woude, F. J., & Yard, B. A. (2004) · Critical Care · doi:10.1186/cc2879 · Cited by 135
S100B protein in the gut: The evidence for enteroglial-sustained intestinal inflammation
Cirillo, C., Sarnelli, G., Esposito, G., Turco, F., Steardo, L., & Cuomo, R. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i10.1261 · Cited by 135
Catecholamine content and in vitro catecholamine synthesis in peripheral human lymphocytes
Musso, N. R., Brenci, S., Setti, M., Indiveri, F., & Lotti, G. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.10.8855800 · Cited by 134
Direct evidence for expression of dopamine receptors in astrocytes from basal ganglia
Miyazaki, I., Asanuma, M., Diaz-Corrales, F. J. J., Miyoshi, K., & Ogawa, N. (2004) · Brain Research · doi:10.1016/j.brainres.2004.09.014 · Cited by 134
Tetrahydrobioterin (BH4) pathway: from metabolism to neuropsychiatry
Fanet, H., Capuron, L., Castanon, N., Calon, F., & Vancassel, S. (2021) · Current Neuropharmacology · doi:10.2174/1570159x18666200729103529 · Cited by 134
The Chemokine CCL2 Mediates the Seizure-enhancing Effects of Systemic Inflammation
Cerri, C., Genovesi, S., Allegra, M., Pistillo, F., Püntener, U., Guglielmotti, A., Perry, V. H., Bozzi, Y., & Caleo, M. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0451-15.2016 · Cited by 133
HIV infects astrocytes in vivo and egresses from the brain to the periphery
Lutgen, V., Narasipura, S., Barbian, H. A., Richards, M. H., Wallace, J., Razmpour, R., Buzhdygan, T. P., Ramirez, S., Prevedel, L., Eugenin, E., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008381 · Cited by 133
Kaalund, S. S., Newburn, E. N., Ye, T., Tao, R., Li, C., Deep-Soboslay, A., Herman, M. M., Hyde, T. M., Weinberger, D. R., Lipska, B. K., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.165 · Cited by 132
Bortolanza, M., Cavalcanti-Kwiatkoski, R., Padovan‐Neto, F. E., da-Silva, C. A., Mitkovski, M., Raisman‐Vozari, R., & Bel, E. A. D. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.10.017 · Cited by 132
Gaskill, P. J., Carvallo, L., Eugenin, E. A., & Berman, J. W. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-203 · Cited by 132
Self-citationEmerging roles of basophils in allergic inflammation
Miyake, K., & Karasuyama, H. (2017) · Allergology International · doi:10.1016/j.alit.2017.04.007 · Cited by 132
Fluorescent Biosensors for Neurotransmission and Neuromodulation: Engineering and Applications
Leopold, A. V., Shcherbakova, D. M., & Verkhusha, V. V. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00474 · Cited by 132
Cognitive disorders in people living with HIV
Winston, A., & Spudich, S. (2020) · The Lancet HIV · doi:10.1016/s2352-3018(20)30107-7 · Cited by 132
Barnum, C. J., Jaunarajs, K. L. E., Dupre, K. B., Blandino, P., Deak, T., & Bishop, C. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.07.016 · Cited by 131
Cholinergic Drugs for Alzheimer's Disease Enhance in Vitro Dopamine Release
Zhang, L., Zhou, F.-M., & Dani, J. A. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000299 · Cited by 130
Friedman, E., Jin, L., Cai, G., Hollon, T. R., Drago, J., Sibley, D. R., & Wang, H.-Y. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.1.6 · Cited by 130
Excretion of Noradrenaline, Adrenaline, and Hydroxytyramine in Urine
von Euler, U. S., & Hellner, S. (1951) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1951.tb00765.x · Cited by 129
Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia.
Rottenberg, D. A., Sidtis, J. J., Strother, S. C., Schaper, K. A., Anderson, J., Nelson, M. J., & Price, R. W. (1996) · PubMed · Cited by 129
Evidence against dopamine D1/D2 receptor heteromers
Frederick, A. L., Yano, H., Trifilieff, P., Vishwasrao, H. D., Biezonski, D. K., Mészáros, J., Urizar, E. T., Sibley, D. R., Kellendonk, C., Sonntag, K., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.166 · Cited by 128
Liukkonen, T., Räsänen, P., Jokelainen, J., Leinonen, M., Järvelin, M.-R., Meyer-Rochow, V. B., & Timonen, M. (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2011.02.001 · Cited by 127
Li, C., Xi, Y., Li, S., Zhao, Q. S., Cheng, W., Wang, Z., Zhong, J., Niu, X., & Chen, G. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.07.013 · Cited by 127
Tuberoinfundibular dopamine neurons and the regulation of prolactin secretion
Gudelsky, G. A. (1981) · Psychoneuroendocrinology · doi:10.1016/0306-4530(81)90044-5 · Cited by 127
Thomas, M. P., Chartrand, K., Reynolds, A. D., Vitvitsky, V., Banerjee, R. V., & Gendelman, H. E. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04315.x · Cited by 127
Vuillermot, S., Joodmardi, E., Perlmann, T., Ove Ögren, S., Feldon, J., & Meyer, U. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4831-11.2012 · Cited by 127
Patterns of drug use and HIV infection among adults in a nationally representative sample
Shiau, S., Arpadi, S. M., Yin, M. T., & Martins, S. S. (2017) · Addictive Behaviors · doi:10.1016/j.addbeh.2017.01.015 · Cited by 127
Increased Macrophages and C1qA, C3, C4 Transcripts in the Midbrain of People With Schizophrenia
Purves-Tyson, T. D., Robinson, K., Brown, A. M., Boerrigter, D., Cai, H. Q., Weissleder, C., Owens, S. J., Rothmond, D. A., & Weickert, C. S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02002 · Cited by 127
Capellino, S., Cosentino, M., Wolff, C., Schmidt, M., Grifka, J. K., & Straub, R. H. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.119701 · Cited by 125
Melis, M. R., Succu, S., & Argiolas, A. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb00725.x · Cited by 125
Dopamine and norepinephrine uptake and metabolism by astroglial cells in culture
Pelton, E. W., Kimelberg, H. K., Shipherd, S. V., & BOURKE, R. S. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90322-2 · Cited by 125
Hemby, S. E., Martin, T. J., Co, C., Dworkin, S. I., & Smith, J. E. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09511-4 · Cited by 125
Stimulation of Dopamine Receptor D5 Expressed on Dendritic Cells Potentiates Th17-Mediated Immunity
Prado, C., Contreras, F., González, H., Díaz, P., Elgueta, D., Barrientos, M., Herrada, A. A., Lladser, Á., Bernales, S., & Pacheco, R. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103096 · Cited by 125
Tsai, S., Chuang, J., Tsai, M.-S., Wang, X.-F., Xi, Z., Hung, J., Chang, W., Bonci, A., & Su, T. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518894112 · Cited by 125
Mapping inflammation onto mood: inflammatory mediators of anhedonia
Swardfager, W., Rosenblat, J. D., Benlamri, M., & McIntyre, R. S. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.02.017 · Cited by 125
Effect of dopamine on gastrointestinal motility during critical illness
Dive, A., Foret, F., Jamart, J., Bulpa, P., & Installé, E. (2000) · Intensive Care Medicine · doi:10.1007/s001340051279 · Cited by 124
Fishburn, C. S., Belleli, D., David, C., Carmon, S., & Fuchs, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53401-3 · Cited by 124
Kumar, A. M., Borodowsky, I., Fernandez, B., Gonzalez, L. E., & Kumar, M. (2007) · Journal of NeuroVirology · doi:10.1080/13550280701327038 · Cited by 124
Freddolino, L., Kalani, M. Y. S., Vaidehi, N., Floriano, W. B., Hall, S. E., Trabanino, R. J., Kam, V. W. T., & Goddard, W. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308751101 · Cited by 124
Drugs of Abuse, Dopamine, and HIV-Associated Neurocognitive Disorders/HIV-Associated Dementia
Purohit, V., Rapaka, R. S., & Shurtleff, D. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8195-z · Cited by 122
Saha, B., Mondal, A. C., Majumder, J., Basu, S., & Dasgupta, P. (2001) · NeuroImmunoModulation · doi:10.1159/000049004 · Cited by 122
Guitart, X., Navarro, G., Moreno, E., Yano, H., Cai, N.-S., Sánchez‐Soto, M., Barodia, S. K., Naidu, Y. T., Mallol, J., Cortés, A., et al. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.093096 · Cited by 122
Dopamine-1-mediated Stimulation of Phospholipase C Activity in Rat Renal Cortical Membranes
Felder, C. C., Blecher, M., & José, P. A. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81855-5 · Cited by 121
Trudler, D., Weinreb, O., Mandel, S. A., Youdim, M. B. H., & Frenkel, D. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12633 · Cited by 121
Volume Transmission in Central Dopamine and Noradrenaline Neurons and Its Astroglial Targets
Fuxé, K., Agnati, L. F., Marcoli, M., & Borroto‐Escuela, D. O. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1574-5 · Cited by 121
Memantine agonist action at dopamine D2High receptors
Seeman, P. M., Caruso, C. M., & Lasaga, M. (2007) · Synapse · doi:10.1002/syn.20472 · Cited by 121
SPOKES, E. G. S., & Koch, D. (1978) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1978.tb12477.x · Cited by 121
Ronovsky, M., Berger, S., Zambon, A., Reisinger, S. N., Horvath, O., Pollak, A. J., Lindtner, C., Berger, A., & Pollak, D. D. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.10.016 · Cited by 121
Fernández-Egea, E., Vértes, P. E., Flint, S. M., Turner, L., Mustafa, S. J., Hatton, A., Smith, K. G. C., Lyons, P. A., & Bullmore, E. T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155631 · Cited by 120
Microglia: A Central Player in Depression
Deng, S.-L., Chen, J.-G., & Wang, F. (2020) · Current Medical Science · doi:10.1007/s11596-020-2193-1 · Cited by 119
Lasselin, J., Elsenbruch, S., Lekander, M., Axelsson, J., Karshikoff, B., Grigoleit, J., Engler, H., Schedlowski, M., & Benson, S. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.01.003 · Cited by 119
Calabrese, J. R., Durgam, S., Satlin, A., Vanover, K. E., Davis, R. E., Chen, R., Kozauer, S. G., Mates, S. L., & Sachs, G. S. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2021.20091339 · Cited by 119
Bhatt, S., Hillmer, A. T., Girgenti, M. J., Rusowicz, A., Kapinos, M., Nabulsi, N., Huang, Y. H., Matuskey, D., Angarita, G. A., Esterlis, I., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15930-5 · Cited by 118
Comorbidity of Allergic and Autoimmune Diseases Among Patients With ADHD
Chen, M., Su, T., Chen, Y.-S., Hsu, J.-W., Huang, K., Chang, W.-H., Chen, T., & Bai, Y. (2013) · Journal of Attention Disorders · doi:10.1177/1087054712474686 · Cited by 117
Bone Marker and Bone Density Responses to Dopamine Agonist Therapy in Hyperprolactinemic Males
Di Somma, C. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.3.807 · Cited by 117
Impact of Brain Insulin Signaling on Dopamine Function, Food Intake, Reward, and Emotional Behavior
Kleinridders, A., & Pothos, E. N. (2019) · Current Nutrition Reports · doi:10.1007/s13668-019-0276-z · Cited by 117
Marino, F., Cosentino, M., Bombelli, R., Ferrari, M., Lecchini, S., & Frigo, G. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(98)00057-5 · Cited by 115
Principles of inflammasome priming and inhibition: implications for psychiatric disorders
Herman, F. J., & Pasinetti, G. M. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.06.010 · Cited by 115
Cited by
Uncovering the metabolic impact of acute psychological stress in young adults
Frempong, G. A., Goni, G., Lorenzo-Tejedor, M., De la Cámara, C., Lázaro, J., Mangialavori Rasia, E., Aguiló, J., Bailon, R., & Bernal, M. L. (2026) · Scientific Reports · doi:10.1038/s41598-025-29572-4 · Cited by 3
Metadata
- Authors
- Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J., & Gaskill, P. J.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2023-01
- Volume
- 75
- Issue
- 1
- Pages
- 62-158
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W4311937162
- Cited by
- 308
- References
- 1,227
- FWCI
- 13.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.